» Articles » PMID: 31257569

Could Autonomic Nervous System Parameters Be Still Helpful in Identifying Patients with Left Ventricular Systolic Dysfunction at the Highest Risk of All-cause Mortality?

Overview
Journal Cardiol J
Date 2019 Jul 2
PMID 31257569
Citations 1
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Autonomic imbalance is associated with poor prognosis of patients with systolic dysfunction. Most of the previous data were written several years ago and constituted to cardiovascular or arrhythmic mortality. The current treatment of these patients has improved substantially over the last decades, and thus, the population at risk of death may have altered as well. Consequently, data on high-risk patients with systolic dysfunction in the modern era are sparse and those from previous trials may no longer be applicable. The aim herein, was to verify whether well-known autonomic indices - baroreflex sensitivity (BRS) and heart rate variability (HRV) - remain accurate predictors of mortality in patients with systolic dysfunction.

Methods: Non-invasively obtained BRS and HRV were analyzed in 205 clinically stable patients with left ventricular ejection fraction (LVEF) ≤ 40%. 28 patients died within 28 ± 9 month follow-up.

Results: Baroreflex sensitivity, low-frequency (LF) in normalized units, LF to high-frequency ratio and standard deviation of average R-R intervals were significantly associated with mortality; cut-off values of the highest discriminatory power for abovementioned parameters were ≤ 3.0 ms/mmHg, ≤ 41, ≤ 0.7 and ≤ 25 ms, respectively. In bivariate Cox analyses (adjusted for LVEF, New York Heart Association [NYHA] or absence of implantable cardioverter-defibrillator [ICD]) autonomic indices remain significant predictors of death.

Conclusions: Baroreflex sensitivity and HRV - may still be helpful in identifying patients with left ventricular systolic dysfunction at the highest risk of all-cause mortality, independently of LVEF, NYHA class, and ICD implantation.

Citing Articles

Baroreflex sensitivity but not microvolt T-wave alternans can predict major adverse cardiac events in ischemic heart failure.

Kaufmann D, Raczak G, Szwoch M, Wabich E, Swiatczak M, Danilowicz-Szymanowicz L Cardiol J. 2020; 29(6):1004-1012.

PMID: 33001423 PMC: 9788737. DOI: 10.5603/CJ.a2020.0129.

References
1.
Danilowicz-Szymanowicz L, Kaufmann D, Rozwadowska K, Kempa M, Lewicka E, Raczak G . Microvolt T-wave alternans and autonomic nervous system parameters can be helpful in the identification of low-arrhythmic risk patients with ischemic left ventricular systolic dysfunction. PLoS One. 2018; 13(5):e0196812. PMC: 5933691. DOI: 10.1371/journal.pone.0196812. View

2.
Ponikowski P, Anker S, Chua T, Szelemej R, Piepoli M, Adamopoulos S . Depressed heart rate variability as an independent predictor of death in chronic congestive heart failure secondary to ischemic or idiopathic dilated cardiomyopathy. Am J Cardiol. 1997; 79(12):1645-50. DOI: 10.1016/s0002-9149(97)00215-4. View

3.
Schwartz P, La Rovere M, De Ferrari G, Mann D . Autonomic modulation for the management of patients with chronic heart failure. Circ Heart Fail. 2015; 8(3):619-28. DOI: 10.1161/CIRCHEARTFAILURE.114.001964. View

4.
La Rovere M, Pinna G, Maestri R, Barlera S, Bernardinangeli M, Veniani M . Autonomic markers and cardiovascular and arrhythmic events in heart failure patients: still a place in prognostication? Data from the GISSI-HF trial. Eur J Heart Fail. 2012; 14(12):1410-9. DOI: 10.1093/eurjhf/hfs126. View

5.
De Ferrari G, Stolen C, Tuinenburg A, Wright D, Brugada J, Butter C . Long-term vagal stimulation for heart failure: Eighteen month results from the NEural Cardiac TherApy foR Heart Failure (NECTAR-HF) trial. Int J Cardiol. 2017; 244:229-234. DOI: 10.1016/j.ijcard.2017.06.036. View